MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
about
Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.Gd Complexes of DO3A-(Biphenyl-2,2'-bisamides) Conjugates as MRI Blood-Pool Contrast Agents.Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat gliomaHiSStology: high spectral and spatial resolution magnetic resonance imaging detection of vasculature validated by histology and micro-computed tomographyVascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.Magnetic Resonance Imaging of Human Tissue-Engineered Adipose Substitutes.Imaging of tumor angiogenesis: functional or targeted?Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbitsDevelopment of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.Visualizing vascular permeability and lymphatic drainage using labeled serum albuminDynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts.Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI.A novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI.Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis.Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancer.
P2860
Q30651989-E6D9ECF2-186F-4B8E-90AC-F11CB660785BQ30829168-D7E201B8-E241-49CB-B979-250319D44F09Q33525581-D299151E-6B78-4313-81DC-631F0BCCDE73Q33857065-C61AA797-8D4E-49B5-8955-36762425E845Q35581064-DBA71C45-0BED-48ED-9C57-66CE94337C01Q35844391-FDFC83A1-FA2F-4E1B-879D-BCF4954BC2E3Q36469164-9B985E89-FFF1-4C2A-8BE5-036883EAD04CQ36804990-C580FA61-01E8-43B0-A476-2720E81A6C4AQ36914981-4A96661B-3A5E-4D5A-854D-C7E287D5F28CQ36972860-B48982AC-24F0-491F-BA50-B5DADC8304E8Q37761659-8FA85E5E-7A91-47EC-8425-D16EF14C1710Q38168371-99BDDE91-2CA2-4424-80B3-A2ED9190ED6BQ39116695-FE2B8226-9A94-4630-8C04-CDC3488A69D2Q40051004-863E99DC-15A6-4F6A-B3E5-2E3EFA61A9F5Q40120520-3D28E56C-E42A-47AC-9628-BB880363AC25Q41110202-34F4C0B2-182D-4ABC-BFBF-A44151F7BF8AQ42152039-81A15741-0B0B-461A-A3D8-CB6A704C017AQ55286810-11EC1D5E-538A-4A97-A472-CC3A906BA8D9
P2860
MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
MRI monitoring of Avastin anti ...... imental model of human cancer.
@en
type
label
MRI monitoring of Avastin anti ...... imental model of human cancer.
@en
prefLabel
MRI monitoring of Avastin anti ...... imental model of human cancer.
@en
P2093
P2860
P356
P1476
MRI monitoring of Avastin anti ...... imental model of human cancer.
@en
P2093
Anda Preda
David M Shames
Friedrich M Cavagna
Karl Turetschek
Martina Möglich
Robert C Brasch
Timothy P L Roberts
Viktor Novikov
P2860
P304
P356
10.1002/JMRI.20184
P577
2004-11-01T00:00:00Z